Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 02, 2019
LSNE announces approval of an ANDA from the FDA, for a sterile injectable product manufactured at their aseptic fill finish facility in León, Spain.
read more
Tuesday, October 12, 2021
LSNE Contract Manufacturing, a leading global contract development and manufacturing organization (CDMO), today announces it has doubled its sterile drug product lyophilization capacity at its Madison, Wisconsin parenteral manufacturing facility, ...
read more
Lyophilization Services of New England (LSNE) announced the acquisition of a sterile injectables manufacturing facility located in León, Spain.
read more
LSNE has received GMP certification from Brazil's National Health Surveillance Agency - ANVISA following an inspection and audit of its manufacturing facility in Manchester, NH in February.
read more
LSNE announced a strategic plan to expand its QC laboratory in Bedford and provide new employment opportunities for its analytical and operations workforce.
read more
Lyophilization Services of New England has acquired PSC Biotech’s cGMP aseptic fill finish manufacturing facility located in Madison, Wisconsin
read more
Bristol Myers Squibb and LOTTE Corporation announced that LOTTE has agreed to purchase Bristol Myers Squibb’s manufacturing facility in East Syracuse, New York.
read more
Wednesday, January 19, 2022
Forbion, BioGeneration Ventures and Lonza announced the extension of their collaboration to include the development and manufacturing of small molecules.
read more
Wednesday, April 03, 2019
Chr. Hansen Holding A/S and Lonza have signed an agreement to establish a 50/50 joint venture to develop the live biotherapeutic products (LBPs) industry.
read more
Lonza announced an investment in a major expansion of Highly Potent API (HPAPI) capacity at its Visp, CH site.
read more
Monday, December 10, 2018
Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou.
read more
Following the recent FDA approval of the PAS for second-generation Andexxa, Portola and Lonza announce the start of supply of the recombinant coagulation factor from Lonza’s Porriño facility.
read more
Lonza has selected Rockwell Automation for the turnkey implementation of the Lonza strategic vision of bringing the digital factory to nine former Capsugel facilities that manufacture drug capsules.
read more
Monday, November 19, 2018
Lonza Pharma & Biotech has opened its Collaborative Innovation Center (CIC) in the Haifa Life Science Park, Israel.
read more
Lonza is opening a dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies.
read more